Pilot trial of Dronabinol adjunctive treatment of agitation in Alzheimer's disease (THC‐AD).

MLA

Rosenberg, Paul B., et al. “Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer’s Disease (THC‐AD).” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, June 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1002/alz.064983.

APA

Rosenberg, P. B., Outen, J. D., Amjad, H., Burhanullah, H., Vandrey, R., Nowrangi, M. A., Schultz, M., Isesalaya, M., Castaneda, R., Agronin, M., Walsh, P., Drury, M., Ozonsi, R., Cohen, L., Wilkins, J. M., Harper, D. G., & Forester, B. P. (2023). Pilot trial of Dronabinol adjunctive treatment of agitation in Alzheimer’s disease (THC‐AD). Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19, 1–3. https://doi.org/10.1002/alz.064983

Chicago

Rosenberg, Paul B., John D. Outen, Halima Amjad, Haroon Burhanullah, Ryan Vandrey, Milap A. Nowrangi, Meghan Schultz, et al. 2023. “Pilot Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer’s Disease (THC‐AD).” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (June): 1–3. doi:10.1002/alz.064983.